3Hughes RA,Bouche P,Cornblath DR,et al.European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy:report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.Eur J Neurol,2006,13:326-332.
4Feldman EL,Grisold W,Russell JW,et al.Atlas of neuromuscular diseases--A practice guideline.New York:Springer,2004.
5K(o)ller H,Schroeter M,Kieseier BC,et al.Chronic inflammatory demyelinating polyneuropathy--update on pathogenesis,diagnostic criteria and therapy.Curr Opin Neurol,2005,18:273-278.
6Elovaara I,Apostolski S,van Doorn P,et al.EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases:EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.Eur J Neurol,2008,15:893-908.
7Ropper AH,Brown RH.Adams and Victor's principles of neurology.8th ed.Columbus:McGraw-Hill Professional,2005.
8French CIDP Study Group.Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy.J Neurol Neurosurg Psychiatry,2008,79:115-118.
